Adcon-L: Marketed

Researchers presented Phase IV data showing that 50 Adcon-L patients, who had previously undergone spinal surgery and then received Adcon-L in a second surgery, had a 54 percent reduction in radicular pain (p=0.001) and a 73 percent reduction of activity-related pain (p=0.001) compared to patients who did not receive Adcon-L. ...